Joshua M. Hare, M.D., F.A.C.C

Louis Lemberg Professor of Medicine
Director, Interdisciplinary Stem Cell Institute (ISCI)

tel: 305-243-1998
fax: 305-585-5825

Send an email to Joshua M. Hare, M.D., F.A.C.C

For Patients

Board Certifications
American Board of Internal Med-Cardiovascular Disease

Practice Locations
University of Miami Hospital/Sylvester

Languages Spoken
English

Appointments
For an appointment, please call 305-243-4813 or use our online appointment form

Education

Harvard University
Boston, MA 		Research Fellow Medicine 1994
The Brigham and Women's Hospital
Boston, MA 		Fellowship Cardiovascular Disease 1994
Harvard School of Public Health
Boston, MA 		Program in Clinical Effectiveness 1992
The Johns Hopkins Hospital
Boston, MA 		Residency Medicine 1991
Johns Hopkins University
Boston, MA 		Fellowship Internal Medicine 1991
The Johns Hopkins Hospital
Baltimore, MD 		Internship Medicine 1989
Johns Hopkins University School of Medicine
Baltimore, MD 		M.D. 1988
University of Pennsylvania
Philadelphia, PA 		B.A. 1984

Areas of Specialization

  • Heart failure
  • Heart transplantation
  • Myocarditis
  • Cardiomyopathy
  • Stem cell therapy

Joshua Michael Hare, M.D., is chief of the Division of Cardiology, Louis Lemberg professor of medicine, professor of molecular and cellular pharmacology, and director of the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine. Dr. Hare graduated from the University of Pennsylvania and has a medical degree from Johns Hopkins University. He did his residency at Hopkins and fellowships at Hopkins, Harvard University and The Brigham and Women's Hospital in Boston. Dr. Hare was Professor of Medicine and Biomedical Engineering and director of cardiac transplantation at Johns Hopkins, leading their heart failure program, before he joined the faculty at University of Miami.

Dr. Hare is one of the world's leading pioneers in the use of stem cell therapy to repair damaged hearts. He recently released findings on the first human clinical trial testing a stem-cell based treatment for heart attack patients, which showed the stem cell treated patients had lower rates of cardiac arrhythmias, and had significant improvements in heart, lung and symptom status. His work is widely published and has included recent articles in The New England Journal of Medicine, Nature, Proceedings of the National Academy of Sciences, Circulation, and Circulation Research. Dr. Hare is the principal investigator on a National Institutes of Health Specialized Center for Cell-Therapy (SCCT) funded stem cell study for patients with congestive heart failure.